Global Kyphoplasty and Percutaneous Discectomy Procedure Market- Drivers
Increasing prevalence of Vertebral Compression Fractures (VCF), osteoporosis, and other spinal disorders is expected to drive market growth over the forecast period. For instance, according to the American Association of Neurological Surgeons, VCFs are the most common fracture in patients with osteoporosis, that affect about 750,000 people annually in the U.S. VCFs affect an estimated 25% of all postmenopausal women in the U.S.
The increasing demand for minimally invasive surgical procedures in orthopedics and thereby improvements in reimbursement policies is expected to further drive the market growth. For instance, in September 2020, the SpineJack implantable fracture reduction system of Stryker, a multinational medical technologies company, received the U.S. Centers for Medicare & Medicaid Services (CMS) New Technology Add-on Payment (NTAP) as part of the 2021 inpatient prospective payment system. The SpineJack System is an implanted fracture reduction system, intended to reduce vertebral compression fractures. After the SpineJack implant is inserted, it is expanded, and Vertaplex HV bone cement is injected at a low pressure to stabilize the restored vertebral body.
Global Kyphoplasty and Percutaneous Discectomy Procedure Market: Restraint
The high cost of minimally invasive procedures is expected to hamper the market growth. The price of spinal surgeries is very high, which can hamper the market growth. For instance, according to New Choice Health, Inc., a free, consumer-focused healthcare marketplace, the national average cost of vertebral augmentation surgery such as vertebroplasty and kyphoplasty is US$ 36,880 in the U.S. According to the same source, the average price range for kyphoplasty is US$ 11,300 to US$ 31,000 in the U.S.
Kyphoplasty and Percutaneous Discectomy Procedure Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients